DB19397InvestigationalProtein Based Therapies
AZD8630 is an experimental drug under investigation, as described in the Phase I clinical study titled "Randomised, Blinded, Placebo-controlled Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics (NCT05110976).
- Mechanism
- Curator reviewed
Pharmacologically active on Thymic stromal lymphopoietin
- Code names
- AZD8630
Resolves to
Compound
Targets
What you can answer from here — as of April 23, 2025
Which drugs share a target with AZD8630, and which of those have an active Phase 3 trial?
Create a free account or log in to explore the full data card.
Create Account